Morphology and surface states of colloidal probucol nanoparticles evaluated by atomic force microscopy

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 6, 2008, Pages 878-880

  Moribe, Kunikazu ^a   Wanawongthai, Chalermphon ^a   Shudo, Jyutaro ^a   Higashi, Kenjirou ^a   Yamamoto, Keiji ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Atomic force microscopy; Colloidal nanoparticle; Grinding; Probucol; Surface state

Indexed keywords

DODECYL SULFATE SODIUM; NANOPARTICLE; POVIDONE; PROBUCOL;

ABSORPTION; ARTICLE; ATOMIC FORCE MICROSCOPY; COLLOID; COMPARATIVE STUDY; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG MIXTURE; DRUG STRUCTURE; IMAGE ANALYSIS; MOLECULE; MORPHOLOGY; PARTICLE SIZE; SURFACE PROPERTY;

ANIMALS; ANTICHOLESTEREMIC AGENTS; COLLOIDS; INTESTINAL ABSORPTION; MALE; MICROSCOPY, ATOMIC FORCE; NANOPARTICLES; PARTICLE SIZE; PROBUCOL; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES; SUSPENSIONS;

EID: 45749129355     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.878     Document Type: Article

References (16)

1. Vogt M., Kunath K., Dressman J. B., Eur. J. Pharm. Biopharm., 68, 330-337 (2008).
2. Kubo H., Osawa T., Takashima K., Mizobe M., Biol. Pharm. Bull., 19, 741-747 (1996).
3. Sugimoto M., Okagaki T., Narisawa S., Koida Y., Nakajima K., Int. J. Pharm., 160, 11-19 (1998).
4. Liversidge G. G., Cundy K. C., Int. J. Pharm., 125, 91-97 (1995).
5. Wu Y., Loperb A., Landisb E., Hettricka L., Novaka L., Lynna K., Chenc C., Thompsona K., Higginsd R., Batrad U., Shelukard S., Kweia G., Storeye D., Int. J. Pharm., 285, 135-146 (2004).
6. Merisko-Liversidge E., Sarpotdar P., Bruno J., Hajj S., Wei L., Peltier N., Rake J., Shaw J. M., Pugh S., Polin L., Jones J., Corbett T., Cooper E., Liversidge G. G., Pharm. Res., 13, 272-278 (1996).
7. Wiedman T. S., De Castro L., Wood R. W., Pharm. Res., 14, 112-116 (1997).
8. Shi H. G., Farber L., Michaels J. N., Dickey A., Thompson K. C., Shelukar S. D., Hurter P. N., Reynolds S. D., Kaufman M. J., Pharm. Res., 20, 479-484 (2003).
9. Itoh K., Pongpeerapat A., Tozuka Y., Oguchi T., Yamamoto K., Chem. Pharm. Bull., 51, 171-174 (2003).
10. Moribe K., Pongpeerapat A., Tozuka Y., Yamamoto K., Pharmazie, 61, 95-101 (2006).
11. Pongpeerapat A., Itoh K., Tozuka Y., Moribe K., Oguchi T., Yamamoto K., J. Drug Del. Sci. Tech., 14, 441-447 (2004).
12. Pongpeerapat A., Higashi K., Tozuka Y., Moribe K., Yamamoto K., Pharm. Res., 23, 2566-2574 (2006).
13. Pongpeerapat A., Wanawongthai C., Tozuka Y., Moribe K., Yamamoto K., Int. J. Pharm., 352, 309-316 (2008).
14. Jiang B., Hu L., Gao C., Shen J., Int. J. Pharm., 304, 220-230 (2005).
15. Rodríguez-Hernández J., Babin J., Zappone B., Lecommandoux S., Biomacromolecules, 6, 2213-2220 (2005).
16. Shudo J., Pongpeerapat A., Wanawongthai C., Moribe K., Yamamoto K., Biol. Pharm. Bull., 31, 321-325 (2008).